[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":8296000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":61885000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":61725000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":15000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":175000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2147000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":180000.0,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q1_USD":39000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2147000.0,"OtherLiabilitiesCurrent_0_Q1_USD":753000.0,"ShortTermInvestments_0_Q1_USD":61885000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":112800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":51417000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":15.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":19000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":900000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":55000.0,"InvestmentIncomeInterest_1_Q1_USD":556000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":19000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-17341000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":14.44,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":18686000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":804.0,"OtherAssetsCurrent_0_Q1_USD":775000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":20.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":10591000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q1_USD":0.0,"RestrictedCashNoncurrent_0_Q1_USD":500000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":39285000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":22886000.0,"OtherNoncashIncomeExpense_1_Q1_USD":19000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2445000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4648000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":753000.0,"OperatingLeaseLiability_0_Q1_USD":5401000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1222000.0,"CommonStocksIncludingAdditionalPaidInCapital_0_Q1_USD":219432000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":847000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1208000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1244000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1280000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":871000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":6623000.0,"InterestReceivableCurrent_0_Q1_USD":139000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q1_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1173000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":8.04,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":1397.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":11576000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-111162000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3771000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":6427000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4366000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":60000.0,"NetIncomeLoss_1_Q1_USD":-17360000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-12230000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":16339000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":6482000.0,"LiabilitiesCurrent_0_Q1_USD":10760000.0,"StockholdersEquity_0_Q1_USD":108437000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":123884000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-663000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3991000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.71,"CommonStockSharesOutstanding_0_Q1_shares":24587000.0,"CommonStockSharesIssued_0_Q1_shares":24614000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":50917000.0,"AssetsCurrent_0_Q1_USD":117168000.0,"Assets_0_Q1_USD":123884000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":3896000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":167000.0,"Liabilities_0_Q1_USD":15447000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":24488000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"NonoperatingIncomeExpense_1_Q1_USD":422000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":27600000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":22.56,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.32,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":13.91,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3869.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":5630000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":2391000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1859000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":55000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":42.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":2147000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":13862000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-17782000.0,"OperatingExpenses_1_Q1_USD":17853000.0,"DepreciationAndAmortization_1_Q1_USD":235000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":71000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":6427000.0,"Ticker":"CRNX","CIK":"1658247","name":"CRINETICS PHARMACEUTICALS, INC.","OfficialName":"Crinetics Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1104302360.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]